Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A novel epidemiological model for COVID-19

Mauro Gaspari
doi: https://doi.org/10.1101/2020.07.23.20160580
Mauro Gaspari
Department of Computer Science and Engineering, University of Bologna, Bologna, Italy, Tel.: +39-51-2094875, Fax: +39-51-2094510, E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mauro.gaspari@unibo.it mauro.gaspari@unibo.it
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

COVID-19 is characterized by a large number of asymptomatic and mild cases that are difficult to detect; most of them remain unknown, still having an important role in the transmission of the disease, this makes the pandemic difficult to control. The purpose of this research is to develop an epidemiological model that allows to estimate the number of unknown/asymptomatic cases in a given area.

The SEIAMPR system, a novel simulation based model for COVID-19 is designed and implemented in Python. The intuition of the model is simple: about 80% of COVID-19 infected people evolve as asymptomatic or with a mild clinical course, many of them remain unknown to the authorities, some of them including those in critical conditions are eventually detected and classified as positive cases. The simulator reproduces this process using an adaptive method integrated with official data.

The simulator has been used for modelling the outbreak in 21 regions in Italy. The positive effects of lockdown policies are demonstrated: unknown active cases 12 days after the lockdown (March the 21th) ranged from 284101 to 374038, e.g. many more than all the official cases in Italy, reducing to 10213/20949 the reopening day. The number of unknown active cases at the beginning of June in the Lombardia region ranged from 6813 to 13390 demanding particular attention.

SEIAMPR is simple to tune and integrate with official data, it emerges as an up-and-coming tool for reporting the effect of lockdown measures, the impact of the disease on the population, and the remaining unknown active cases for evaluating the timing of exit strategies.

Mathematics Subject Classification (2010) MSC 68-XX

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No approval was needed for this reaserch.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • A few typos were corrected. Availability information added.

Data Availability

The used data are available in the Italian Civil Protection site. The source code is available upon request.

https://github.com/pcm-dpc

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A novel epidemiological model for COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A novel epidemiological model for COVID-19
Mauro Gaspari
medRxiv 2020.07.23.20160580; doi: https://doi.org/10.1101/2020.07.23.20160580
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A novel epidemiological model for COVID-19
Mauro Gaspari
medRxiv 2020.07.23.20160580; doi: https://doi.org/10.1101/2020.07.23.20160580

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5867)
  • Intensive Care and Critical Care Medicine (361)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (231)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2011)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)